MCM
FPRX

Matarin Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Matarin Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,975
Closed -$614K – 309
2017
Q1 		$614K Sell
16,975
-111,686
-87% -$4.04M 0.06% 215
2016
Q4 		$6.45M Buy
128,661
+11,358
+10% +$569K 0.72% 38
2016
Q3 		$6.16M Buy
117,303
+80,898
+222% +$4.25M 0.68% 52
2016
Q2 		$1.51M Buy
+36,405
New +$1.51M 0.2% 152